NEW ACTIVE CANDIDATE DEVELOPED FOR THE TREATMENT OF TYPE 2 DIABETES

A team of researchers from Helmholtz Munich, the German Center for Diabetes Research (DZD) and Novo Nordisk has a new one Hormones-Combination for the future treatment of type 2-Diabetes developed. The scientists found the blood sugar-lowering effects of the drug

more on the subject

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.